In addition, it is interesting to point out that the rate of postsurgical hyperprolactinemia was five times greater in the group of GH&PRL-PAs than in GH-PAs and this may be an indicator of tumoral persistence in cosecreting tumors (3). The gene discussed is GH1; the disease is hyperprolactinemia.